Chitosan is an inexpensive shellfish- or mushroom-derived fiber that binds fats in the gut. Its most dependable effect is a small drop in cholesterol, with slight reductions in weight, body fat, and blood pressure that reverse once stopped. Best seen as an optional add-on. Generally well tolerated; can lower fat-soluble vitamin absorption and strengthen blood thinners. (Full Review)

Protocol

Dose

1–3 g/day

Divided across the two to three largest fat-containing meals

Timing

15–30 min before meals

Taken with a full glass of water before fat-containing meals

Dosing

Split, per meal

Split dosing preferred over a single large dose

Time to effect

Cholesterol

4–12 weeks

Lipid changes emerge with consistent, meal-timed use

Weight

4–12 weeks

Weight and body-fat changes emerge over weeks, not days

Assessment

8–12 weeks

No measurable change by then signals limited value

Benefits

High: Modest reduction in LDL and total cholesterol

Medium: Modest short-term weight loss; small reduction in blood pressure

Low: Improved body composition and lean-mass preservation; blunting of post-meal blood sugar rises

Speculative: Prebiotic-like gut microbiome modulation; antioxidant, anti-inflammatory, and metabolic-longevity signaling

Contraindications

Shellfish allergy (unless fungal-sourced)

Pregnancy or breastfeeding

Significant malabsorption

Chronic constipation

Not a substitute for prescribed lipid-lowering therapy in high-risk individuals

Key Interactions

Vitamin K antagonists (warfarin)

Other prescription oral medications

Fat-soluble vitamins (A, D, E, K) and carotenoids

Over-the-counter fat-soluble products (fish oil, vitamin D, vitamin E, CoQ10)

Additive cholesterol- and blood-pressure-lowering agents

Risk & Side Effects

High: Gastrointestinal disturbances

Medium: Shellfish allergy and hypersensitivity; reduced absorption of fat-soluble vitamins

Low: Enhanced effect of anticoagulants

Speculative: Disruption of beneficial gut bacteria; mineral malabsorption with chronic high-dose use

Monitoring

Marker	Target	Why
LDL cholesterol	< 100 mg/dL (< 80 higher-risk)	Primary marker chitosan may modestly lower
Total cholesterol	150–200 mg/dL	Tracks overall lipid response
Triglycerides	< 90 mg/dL	Chitosan effect here is inconsistent
HDL cholesterol	> 45 (men), > 55 (women)	Confirms the "good" cholesterol is not adversely shifted
Waist circumference / body weight	Waist < 40 in (men), < 35 in (women)	Tracks chitosan's modest body-composition effect
25-hydroxy vitamin D	40–60 ng/mL	Guards against fat-soluble vitamin depletion during long-term use
INR (only if on warfarin)	2.0–3.0	Detects enhanced anticoagulation from a chitosan–warfarin interaction

Cadence: Lipid panel and body measures at 8–12 weeks, then every 6–12 months; vitamin D every 6–12 months for long-term use; INR more often if on warfarin.

Qualitative Assessment

Bowel regularity and any constipation, bloating, or cramping
Appetite and post-meal fullness
Energy levels and general well-being
How clothing fits at the waist over time

Chitosan for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment